On Wednesday, March 8, 2017, the Federal Circuit published its decision in Thales Visionix Inc. v. United States, No. 1:14-cv-00513-TCW, (Mar. 8, 2017) concerning infringement of U.S. Patent No. 6,474,159. Thales Visionix appealed from the US Court of Federal Claims judgment holding that the claims were directed to patent-ineligible subject matter. The Federal Circuit reversed the Claims Court's decision and remanded for further proceedings.
On Wednesday, February 22, 2017, the Supreme Court published its decision in Life Technologies Corp. v. Promega Corp. 580 U.S. __ (2017), concerning infringement of US Patent RE 37,984. The question before the Court was whether supplying a single component of a multicomponent invention overseas constitutes an infringing act under 35 U. S. C. §271(f)(1).